Please login to the form below

Not currently logged in
Email:
Password:

Pfizer may sell drug-delivery unit

Pfizer has announced that it may divest its Capsugel business unit, one of the world's leading providers of hard capsules

Pfizer has announced that it may divest its Capsugel business unit, one of the world's leading providers of hard capsules.

Morgan Stanley has been retained to conduct a strategic review of options for the business unit, and Pfizer is aiming to make an announcement of the results by the first quarter of next calendar year.

"Among Pfizer's robust and broad portfolio, Capsugel now represents a unique business, which we believe has strong potential for growth outside of Pfizer,” Cavan Redmond, senior vice president and group president of Pfizer's Diversified Businesses, said in a statement. "This, combined with Capsugel's consistent performance as well as improved financial market conditions, make it a good time to undertake this review."

Capsugel clients include pharmaceutical, consumer healthcare and dietary supplement companies around the world. The business unit had revenues of $740m in 2009. 

Capsugel's products include hard gelatin, liquid-filled, and vegetarian capsules, as well as liquid formations made using its Licaps Drug Delivery System. The business also sells R&D equipment. Capsugel has manufacturing and business facilities around the world, including locations in the US, Europe, Japan and Australia.

6th October 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics